Literature DB >> 10471330

Effects of anti-PM-Scl 100 (Rrp6p exonuclease) antibodies on prenucleolar body dynamics at the end of mitosis.

N Fomproix1, D Hernandez-Verdun.   

Abstract

Prenucleolar bodies (PNBs) are transitory structures which serve as building blocks for nucleoli at the transition mitosis/interphase. The assembly of PNBs and their pathway are not clearly understood. To better understand these events, the behavior of the PNB-containing PM-Scl 100 protein was compared with that of other PNB proteins. This nucleolar protein was chosen because its yeast homologue, Rrp6p exonuclease [1], is known to participate in late events in 5.8 S rRNA (ribosomal RNA) processing. There was a heterogeneous distribution of nucleolar proteins in different classes of PNBs. The PM-Scl 100 colocalized predominantly with protein B23. The PM-Scl-100-containing PNBs were translocated at later times to nucleoli as opposed to the fibrillarin-containing PNBs. Microinjections of antibodies directed against PM-Scl 100 during mitosis inhibited targeting of PM-Scl 100 to the nucleolus. However fibrillarin and protein B23 still participated in nucleolar assembly in early G1. We conclude that there are different kinds of PNBs whose translocation to the nucleoli follow ordered kinetics. Interestingly, proteins involved in late steps of processing as PM-Scl 100 are translocated late, suggesting that they are not cotranscriptionally associated with the rRNA precursors. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471330     DOI: 10.1006/excr.1999.4578

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

1.  Initiation of nucleolar assembly is independent of RNA polymerase I transcription.

Authors:  T Dousset; C Wang; C Verheggen; D Chen; D Hernandez-Verdun; S Huang
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

2.  Meiotic, cryptic, and stable unannotated transcripts: noncoding RNAs add to the epigenetic tool box controlling meiotic development.

Authors:  Randy Strich
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-03       Impact factor: 11.205

3.  Activities of human RRP6 and structure of the human RRP6 catalytic domain.

Authors:  Kurt Januszyk; Quansheng Liu; Christopher D Lima
Journal:  RNA       Date:  2011-06-24       Impact factor: 4.942

4.  Nucleolar assembly of the rRNA processing machinery in living cells.

Authors:  T M Savino; J Gébrane-Younès; J De Mey; J B Sibarita; D Hernandez-Verdun
Journal:  J Cell Biol       Date:  2001-05-28       Impact factor: 10.539

5.  A role for SUMOylation in snoRNP biogenesis revealed by quantitative proteomics.

Authors:  Belinda J Westman; Angus I Lamond
Journal:  Nucleus       Date:  2011 Jan-Feb       Impact factor: 4.197

6.  Localization of Nopp140 within mammalian cells during interphase and mitosis.

Authors:  Marc Thiry; Thierry Cheutin; Françoise Lamaye; Nicolas Thelen; U Thomas Meier; Marie-Françoise O'Donohue; Dominique Ploton
Journal:  Histochem Cell Biol       Date:  2009-04-18       Impact factor: 4.304

7.  Interdependent nucleocytoplasmic trafficking and interactions of Dis3 with Rrp6, the core exosome and importin-alpha3.

Authors:  Amy C Graham; Stephanie M Davis; Erik D Andrulis
Journal:  Traffic       Date:  2009-02-11       Impact factor: 6.215

8.  Core exosome-independent roles for Rrp6 in cell cycle progression.

Authors:  Amy C Graham; Daniel L Kiss; Erik D Andrulis
Journal:  Mol Biol Cell       Date:  2009-02-18       Impact factor: 4.138

9.  The ribosomal RNA processing machinery is recruited to the nucleolar domain before RNA polymerase I during Xenopus laevis development.

Authors:  C Verheggen; G Almouzni; D Hernandez-Verdun
Journal:  J Cell Biol       Date:  2000-04-17       Impact factor: 10.539

10.  In vivo release of mitotic silencing of ribosomal gene transcription does not give rise to precursor ribosomal RNA processing.

Authors:  V Sirri; P Roussel; D Hernandez-Verdun
Journal:  J Cell Biol       Date:  2000-01-24       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.